3d-gene tm substrate of dna microarray (Toray Industries)
Structured Review
3d Gene Tm Substrate Of Dna Microarray, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tm+dna+microarray/3dgene++mirna+labeling+kit/pmc03029327-243-19-9
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Coccomyxa subellipsoidea KJ Components Enhance the Expression of Metallothioneins and Th17 Cytokines during Human T Cell Activation. Article Snippet: Microarray analysis on a Article Title: Pancreatic cancer detection kit or device, and detection method Article Snippet: Article Title: A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer. Article Snippet: Total RNA, which was extracted from 300-μL Article Title: Kit, device and method for detecting prostate cancer Article Snippet: Fluorescence intensity was digitized using Extraction:Article Title: Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer. Article Snippet: We analyzed the long-term outcomes and developed the candidate predictors of pathological complete response (pCR) in patients with operable breast cancer receiving S-1 + docetaxel.. The 5year disease-free and overall survival (OS) rates were 80.7% and 90.9%, respectively.. Patients who achieved pCR had a longer OS rate than non-pCR patients. Article Title: Lung regeneration with rat fetal lung implantation and promotion of alveolar stem cell differentiation by corticosteroids. Article Snippet: The labeled RNAs were hybridized onto a 3D-Gene Rat miRNA Oligo chip (Toray Industries Inc.). .. After stringent washes, fluorescent signals were scanned using a 3D-Gene Scanner (Toray Industries Inc.) and analyzed using Software:Article Title: Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer. Article Snippet: We analyzed the long-term outcomes and developed the candidate predictors of pathological complete response (pCR) in patients with operable breast cancer receiving S-1 + docetaxel.. The 5year disease-free and overall survival (OS) rates were 80.7% and 90.9%, respectively.. Patients who achieved pCR had a longer OS rate than non-pCR patients. Article Title: Lung regeneration with rat fetal lung implantation and promotion of alveolar stem cell differentiation by corticosteroids. Article Snippet: The labeled RNAs were hybridized onto a 3D-Gene Rat miRNA Oligo chip (Toray Industries Inc.). .. After stringent washes, fluorescent signals were scanned using a 3D-Gene Scanner (Toray Industries Inc.) and analyzed using Expressing:Article Title: Characterization of circulating miRNAs in the treatment of primary liver tumors. Article Snippet: Sixty nanograms of total RNA were analyzed using the 3D-Gene miRNA microarray RNA extraction reagent from the liquid sample kit (Toray Industries, Inc., Kanagawa, Japan). .. Comprehensive miRNA expression analysis was performed by using two types of Labeling:Article Title: Characterization of circulating miRNAs in the treatment of primary liver tumors. Article Snippet: Sixty nanograms of total RNA were analyzed using the 3D-Gene miRNA microarray RNA extraction reagent from the liquid sample kit (Toray Industries, Inc., Kanagawa, Japan). .. Comprehensive miRNA expression analysis was performed by using two types of RNA Extraction:Article Title: Performance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions. Article Snippet: The whole blood specimens were collected by Discovery Life Sciences (Huntsville, AL) and processed as described above from five individual non- cancer healthy female donors on a biweekly basis, for a total of six collections per donor. .. Total RNA was extracted from 0.3 mL of serum using the |
